CompletedNot Applicable

Glycemic and Insulinemic Response of Pasta Products in Comparison to Asian Foods

Singapore32 participantsStarted 2018-08-10

Plain-language summary

The aim of the study is to determine the glycaemic and insulinaemic index of pasta products and local foods. It is hypothesized that different pasta cuts and wholegrain composition of pasta and local foods have different GI depending on the nature of the carbohydrate content and the food structure within each food.

Who can participate

Age range

21 Years – 40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy Asian - Indian and Chinese ethnicity * Age between 21-40 years * Body mass index between 18.5 to 25 kg/m2 * Normal blood pressure (\<140/90 mmHg) * Fasting blood glucose \< 6 mmol/L Exclusion Criteria: * Is a current smoker * Is currently pregnant * Have any metabolic diseases (such as diabetes, hypertension etc) * Have known glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) * Have medical conditions and/or taking medications known to affect glycemia(glucocorticoids, thyroid hormones, thiazide diuretics) * Have any major organ dysfunction (e.g. cardiovascular, respiratory, hepatic, renal, gastrointestinal) that may influence taste, olfaction, appetite, digestion, metabolism, absorption or elimination of test foods, nutraceutical or drug * Have any severe food allergy (e.g. anaphylaxis to peanuts) * Have any known allergies to any food components of the study protocol * Have active Tuberculosis (TB) or currently receiving treatment for TB * Have any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV) * Is a study team member or an immediate family of any study team member. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted. * enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study. * Ha…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Glucose

Timeframe: up to 180 minutes

Insulin

Timeframe: up to 180 minutes

Trial details

NCT IDNCT03646812

SponsorSingapore Institute of Food and Biotechnology Innovation

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-06-01

View on ClinicalTrials.gov More Diabetes trials